The Role of Autologous Platelet Concentrates as a Local Antibiotic Delivery System: A Systematic Scoping Review
-
Published:2024-09-06
Issue:9
Volume:13
Page:856
-
ISSN:2079-6382
-
Container-title:Antibiotics
-
language:en
-
Short-container-title:Antibiotics
Author:
Gasparro Roberta1ORCID, Di Spirito Federica2ORCID, Campana Maria Domenica1, Sammartino Gilberto1ORCID, di Lauro Alessandro E.1
Affiliation:
1. Department of Neurosciences, Reproductive Sciences and Oral Sciences, Section of Oral Surgery, University of Naples Federico II, 80131 Naples, Italy 2. Department of Medicine, Surgery and Dentistry, University of Salerno, 84081 Salerno, Italy
Abstract
Objectives: Ongoing research has begun to develop innovative approaches to deliver local antibiotics while minimizing systemic side effects, antimicrobial resistance, and limited tissue penetration. Autologous platelet concentrates (APCs) offer promise in delivering antibiotics directly to infection sites. Despite the interest, a comprehensive evaluation of their effectiveness is lacking. Therefore, this systematic scoping review aims to collect and appraise studies regarding the efficacy of APCs in delivering antibiotics. Methods: A systematic electronic search of PubMed, Scopus, and Web of Science, using a combination of keywords, was conducted up to February 2024. Articles addressing the use of APCs as a local antibiotic delivery system were included. Results: A total of 13 articles, including 10 in vitro studies, 1 in vitro and clinical study, 1 ex vivo study, and 1 clinical study, were selected. Antibiotic loading capacity and release was confirmed in all studies using doxycycline, gentamicin, linezolid, vancomycin, metronidazole, and penicillin. In addition, the antibacterial effect was obtained mainly against E. coli., P. aeruginosa, S. mitis, H. influenzae, S. pneumoniae, and S. aureus. Conclusions: The incorporation of antibiotics into APCs has been proven to facilitate the effective release of antimicrobial agents at optimal concentrations, potentially reducing the incidence of post-operative infections, substituting, or augmenting systemic antibiotic treatment while retaining APCs’ inherent healing properties.
Reference61 articles.
1. Ajulo, S., and Awosile, B. (2024). Global antimicrobial resistance and use surveillance system (GLASS 2022): Investigating the relationship between antimicrobial resistance and antimicrobial consumption data across the participating countries. PLoS ONE, 19. 2. Murugaiyan, J., Kumar, P.A., Rao, G.S., Iskeqandar, K., Hawser, S., Hays, J.P., Mohsen, Y., Adukkadukkam, S., Awuah, W.A., and Jose, R.A.M. (2022). Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics. Antibiotics, 11. 3. Critical Overview on Pure Chitosan-based Scaffolds for Bone Tissue Engineering: Clinical insights in Dentistry;Signorini;Int. J. Med. Sci.,2023 4. Ahangar, P., Li, J., Nkindi, L.S., Mohammadrezaee, Z., Cooke, M.E., Martineau, P.A., Weber, M.H., Saade, E., Nateghi, N., and Rosenzweig, D.H. (2023). A Nanoporous 3D-Printed Scaffold for Local Antibiotic Delivery. Micromachines, 15. 5. Laubach, J.M., and Sani, R.K. (2023). Thermophilic Exopolysaccharide Films: A Potential Device for Local Antibiotic Delivery. Pharmaceutics, 15.
|
|